unknown linearity [Regulatives / Guidelines]

posted by kudra23 – 2012-01-30 11:30 (5247 d 13:47 ago) – Posting: # 8016
Views: 3,024

Dear all,

There are two products (x mg and y mg capsules) for which BE study will be conducted. We want to submit one of the dosage forms as a biowaver.

Although the other criteria is all fulfilled as per the general biowaver criteria defined in the 4.1.6th article of the guideline, linearity of the active is not known. Can you please advise how to proceed?

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
140 visitors (0 registered, 140 guests [including 48 identified bots]).
Forum time: 02:18 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5